Literature DB >> 23677138

Influence of cataract surgery on optical coherence tomography and neurophysiology measurements in patients with retinitis pigmentosa.

Elena Garcia-Martin1, Diego Rodriguez-Mena, Isabel Dolz, Carmen Almarcegui, Laura Gil-Arribas, Maria P Bambo, Jose M Larrosa, Vicente Polo, Luis E Pablo.   

Abstract

PURPOSE: To evaluate the effect of uncomplicated cataract phacoemulsification on the measurements of visual evoked potentials (VEP), pattern electroretinogram (PERG), and macular and retinal nerve fiber layer (RNFL) using 2 spectral-domain optical coherence tomography (OCT) instruments, the Cirrus OCT (Carl Zeiss Meditech) and Spectralis OCT (Heidelberg Engineering), in patients with retinitis pigmentosa (RP), and to assess the reliability of the OCT measurements before and after cataract surgery.
DESIGN: Observational cross-sectional study.
METHODS: Thirty-five eyes of 35 patients with RP (20 men and 15 women, 45-66 years) who underwent cataract phacoemulsification were studied. At 1 month before and 1 month after surgery, visual acuity, VEP, PERG, and 3 repetitions of scans using the RNFL and macular analysis protocols of the Cirrus and Spectralis OCT instruments were performed. The differences in measurements between the 2 visits were analyzed. Repeatability of OCT measurements was evaluated by calculating the coefficients of variation.
RESULTS: VEP amplitude, RNFL thicknesses provided by Cirrus and Spectralis, and macular measurements provided by Cirrus OCT differed between the 2 visits. VEP latency, PERG measurements, and macular thicknesses provided by the Spectralis OCT before surgery did not differ significantly from those after surgery. The OCT repeatability was better after surgery, with lower coefficients of variation for scans performed after surgical removal of the cataract. The nuclear, cortical, and posterior subcapsular types of cataracts did not show different repeatability.
CONCLUSIONS: The presence of cataracts affects VEP amplitude, RNFL, and macular measurements performed with OCT in eyes with RP. Image repeatability significantly improves after cataract phacoemulsification.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23677138     DOI: 10.1016/j.ajo.2013.03.019

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  6 in total

Review 1.  Effects and Prognosis of Cataract Surgery in Patients with Retinitis Pigmentosa.

Authors:  Hailong He; Hao Song; Xiaodie Meng; Kai Cao; Yi-Xin Liu; Jinda Wang; Xiuhua Wan; Zi-Bing Jin
Journal:  Ophthalmol Ther       Date:  2022-09-04

2.  The effect of cataract surgery on blue-yellow and standard-pattern visual-evoked potentials.

Authors:  Matthias Fuest; Niklas Plange; Sarah Jamali; Hendrik Schwarzer; Gernot Roessler; Peter Walter; Babac Mazinani
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-07-17       Impact factor: 3.117

3.  Using Retinal Imaging to Study Dementia.

Authors:  Victor T T Chan; Tiffany H K Tso; Fangyao Tang; Clement Tham; Vincent Mok; Christopher Chen; Tien Y Wong; Carol Y Cheung
Journal:  J Vis Exp       Date:  2017-11-06       Impact factor: 1.355

4.  Impact of B-Scan Averaging on Spectralis Optical Coherence Tomography Image Quality before and after Cataract Surgery.

Authors:  Dominika Podkowinski; Ehsan Sharian Varnousfaderani; Christian Simader; Hrvoje Bogunovic; Ana-Maria Philip; Bianca S Gerendas; Ursula Schmidt-Erfurth; Sebastian M Waldstein
Journal:  J Ophthalmol       Date:  2017-05-23       Impact factor: 1.909

Review 5.  A Review of Complicated Cataract in Retinitis Pigmentosa: Pathogenesis and Cataract Surgery.

Authors:  Yingying Hong; Hongzhe Li; Yang Sun; Yinghong Ji
Journal:  J Ophthalmol       Date:  2020-12-21       Impact factor: 1.909

6.  Cataract surgery in retinitis pigmentosa.

Authors:  Samrat Chatterjee; Deepshikha Agrawal; Deepanshu Agrawal; Swapnil M Parchand; Anupam Sahu
Journal:  Indian J Ophthalmol       Date:  2021-07       Impact factor: 1.848

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.